Agalsidase beta

Details

Files

Generic Name:

Agalsidase beta

Project Status:

Complete

Therapeutic Area:

Fabry Disease

Manufacturer:

Genzyme Canada

Brand Name:

Fabrazyme

Project Line:

Reimbursement Review

Project Number:

SR0007-000

Performance Metric:

N/A — Predated performance metrics

Submission Type:

Initial

Indications:

Fabry Disease

Recommendation Type:

Do not list

Final Recommendation:

November 24, 2004

Recommendation:

Not to list.

Files

Submission Status Report View PDF

Recommendation and Reasons View PDF

Last Updated : February 24, 2004